SCHEMBL6959368

SCHEMBL6959368

CN1C2CC(=O)CC1CN(Cc1ccccc1)C2

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FUCA1 P04066 2/20 0.47
MC4R P32245 1/20 0.46
S1PR1 P21453 1/20 0.45
S1PR5 Q9H228 1/20 0.45
GAA P10253 2/20 0.45
TACR1 P25103 2/20 0.44
SIGMAR1 Q99720 1/20 0.44
ACHE P22303 1/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
OPRM1 P35372 1/20 0.43
DRD2 P14416 1/20 0.42
DRD4 P21917 1/20 0.42
DRD3 P35462 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6964168 0.86 ACHE (0.47) SIGMAR1ACHEALDH1A1OPRM1
SCHEMBL1022483 0.83 OPRM1 (0.54) FUCA1MC4RSIGMAR1ACHEOPRM1
SCHEMBL18713027 0.83 FUCA1 (0.53) FUCA1MC4RS1PR1S1PR5SIGMAR1
SCHEMBL6957907 0.81 FUCA1 (0.47) FUCA1MC4RS1PR1S1PR5SIGMAR1
SCHEMBL4737149 0.81 FUCA1 (0.47) FUCA1MC4RS1PR1S1PR5SIGMAR1
SCHEMBL6952600 0.80 FUCA1 (0.47) FUCA1MC4RS1PR1S1PR5SIGMAR1
SCHEMBL1022425 0.80 FUCA1 (0.50) FUCA1MC4RSIGMAR1ACHEALDH1A1
Hydrochloric Acid SCHEMBL11776272 0.80 OPRM1 (0.51) FUCA1MC4RSIGMAR1ACHEOPRM1
SCHEMBL1449589 0.80 FUCA1 (0.50) FUCA1MC4RSIGMAR1ACHEALDH1A1
SCHEMBL20799611 0.80 FUCA1 (0.53) FUCA1S1PR1S1PR5GAATACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0550550-B1 3,9-DIAZABICYCLO (3.3.1) NONAN-7-YL DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 2003-07-16 EP claimed
EP-0550550-B1 3,9-DIAZABICYCLO (3.3.1) NONAN-7-YL DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 2003-07-16 EP disclosed
EP-0558923-B1 Diazabicyclo derivatives as 5-HT3 antagonists NISSHIN FLOUR MILLING CO (JP) 2000-05-24 EP disclosed
US-5344831-A Antiemetics for treatment of nausea from chemotherapy NISSHIN FLOUR MILLING CO., LTD. (JP) 1994-09-06 US disclosed
EP-0607233-A1 3,9-DIAZABICYCLO(3.3.1)NONANE DERIVATIVES WITH 5-HT3 RECEPTOR ANTAGONIST ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1994-07-27 EP disclosed
EP-0558923-A1 Diazabicyclo derivatives as 5-HT3 antagonists NISSHIN FLOUR MILLING CO., LTD. (JP) 1993-09-08 EP disclosed
EP-0550550-A1 3,9-DIAZABICYCLO (3.3.1) NONAN-7-YL DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Beecham Group p.l.c. (GB) 1993-07-14 EP disclosed
WO-1993007147-A1 3,9-DIAZABICYCLO(3.3.1)NONANE DERIVATIVES WITH 5-HT3 RECEPTOR ANTAGONIST ACTIVITY SMITHKLINE BEECHAM PLC (GB) 1993-04-15 WO disclosed
WO-1992005174-A1 3,9-DIAZABICYCLO (3.3.1) NONAN-7-YL DERIVATIVES, PROCESS AND INTERMEDIATES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM BEECHAM GROUP PLC (GB) 1992-04-02 WO disclosed